Eli Lilly 6 may 2026 Meet the minds behind CrossBridge Bio, Eli Lilly's $300M Houston buy - The Business Journals
Eli Lilly 6 may 2026 Lilly to invest $4.5B more into massive Indiana manufacturing complex - Fierce Pharma
Eli Lilly 5 may 2026 AI is saving pharma billions in manufacturing and back-office work, just not in the lab - the-decoder.com
Eli Lilly 4 may 2026 GLP-1 Boom Sparks Potential 'Bubble Effect,' Shrinking Competition In Big Pharma, Warns Deloitte: 'The Question Is...' - Benzinga
Eli Lilly 2 may 2026 Why Eli Lilly (LLY) Is Up 9.0% After Q1 Beat And Foundayo GLP‑1 Launch - And What's Next - simplywall.st
Eli Lilly 1 may 2026 While Mass. biotech layoffs surge, this pharma company is on a $20B buying spree - MassLive
Eli Lilly 1 may 2026 Eli Lilly boss reports progress in India after Novo's patent expiration - medwatch.com
Eli Lilly 30 abr 2026 Eli Lilly Stock Jumps on Earnings Beat as Zepbound and Mounjaro Sales Skyrocket - Barron's
Eli Lilly 30 abr 2026 Lilly posts another ‘blowout quarter’ as focus turns to Foundayo launch - BioPharma Dive
Eli Lilly 30 abr 2026 Eli Lilly: Stellar Q1 Earnings Put Pharma In Class Of Its Own, It's Ok To Buy Today (LLY) - Seeking Alpha
Eli Lilly 30 abr 2026 Lilly touts 'encouraging' early days for Foundayo obesity launch, even as GLP-1 pill appears to lag Novo's - Fierce Pharma